Two-year data from Eli Lilly’s SURPASS-EARLY trial show reduced A1c, body weight, and cardiovascular risk factors.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/early-introduction-tirzepatide-yields-t2d-benefits-2026a10007pu?src=rss
Author :
Publish date : 2026-03-12 18:19:00
Copyright for syndicated content belongs to the linked Source.